• 11/29/2024

New $2.9 Million Gene Therapy Promises to Remake Hemophilia Treatment

Wall Street Journal

BioMarin’s gene therapy is the first to win Food and Drug Administration approval for adults with the most common form of the bleeding disorder.

https://www.wsj.com/articles/new-2-9-million-gene-therapy-promises-to-remake-hemophilia-treatment-da254ef4